Buy 6-MAPB Powder
1 view
Skip to first unread message
Alpha researchlab updates
Mar 6, 2026, 12:37:28 AM (6 days ago) Mar 6
to Global Trade Forum 24/7
Buy 6-MAPB Powder
Buy 6-MAPB Powder (1-(benzofuran-6-yl)-N-methylpropan-2-amine) is a psychedelic and entactogenic drug which is structurally related to 6-APB and MDMA. It is not known to have been widely sold as a designer drug but has been detected in analytical samples taken from individuals hospitalised after using drug combinations that included other benzofuran derivatives. 6-MAPB was banned in the UK in June 2013, along with 9 other related compounds which were thought to produce similar effects.
Buy 1-(benzofuran-6-yl)-N-methylpropan-2-amine) powder
Note: The rest of the comments are mostly for tracking the history of identifying the contents of this sample.
Initially, the lab’s GC/MS technique could not differentiate between 6-MAPB and 5-MAPB. The substance was tentatively identified as being either 6-MAPB or 5-MAPB.6-apb powder for sale
Erowid ordered several lab standards for similar substances that the lab used to calibrate their GC/MS equipment to better be able to identify this class of substances. After examining these new chemical standards, the lab changed its identification of this sample 6-APDB.
This identification is still tentative because we have not yet been able to acquire a lab standard for 6-APDB. However, the lab is confident that the sample submitted is NOT an -MAPB or -APB.6-apb buy
Effects
The reported effect is the feeling of energy and euphoria, which are as high as those after the ecstasy consumption. The drug is able to increase music appreciation along with trippy and empathogenic qualities. Along with positive results, people who buy 6-MAPB online also report some adverse ones, namely:
hallucinations;
insomnia;
appetite loss and weight loss;
paranoia (severe stage);
tachycardia;
jaw tension.
Researchers warn most users about possible brain damage as well as neurotoxicity, serotonin syndrome. Other adverse body reactions are closely related to those experienced after the intake of MDA. They are more severe than MDMA results. Besides, 6-MAPB for sale can trigger addiction that is as serious as in case with most amphetamines.
Doses can be light (20-40 mg), regular (40-80 mg) and strong ones (80-100 mg). When the agent is insufflated, the doses must be lower to achieve the same results: light – 10-20 mg, regular – 20-40 mg and strong ones – 40-100 mg. When the drug is consumed orally it starts acting within several minutes and promises effects that last for 5 or 10 hours. The after effects remain for nearly 4 more hours. If the compound is insufflated, it works just the same as in case when taken orally.
Chemical and physical data
Formula: C12H15NO
Molar mass: 189.25 g·mol?1
https://alpharesearchlab.net/product/buy-6-mapb-powder/
https://alpharesearchlab.net/product/buy-6-mapb-powder/
Opens in a new wi
Opens in a new window
Buy 4-MeO-PCP CRYSTAL
Buy 4-MeO-PCP CRYSTAL 4-Methoxyphencyclidine (methoxydine, 4-MeO-PCP) is a dissociative anesthetic drug that has been sold online as a research chemical. The synthesis of 4-MeO-PCP was first reported in 1965 by the Parke-Davis medicinal chemist Victor Maddox. A 1999 review published by a chemist using the pseudonym John Q. Beagle suggested the potency of 4-MeO-PCP in man was reduced relative to PCP, two years later Beagle published a detailed description of the synthesis and qualitative effects of 4-MeO-PCP, which he said possessed 70% the potency of PCP. 4-MeO-PCP was the first arylcyclohexylamine research chemical to be sold online, it was introduced in late 2008 by a company trading under the name CBAY and was followed by several related compounds such as 3-MeO-PCP and methoxetamine.
4-MeO-PCP has lower affinity for the NMDA receptor than PCP, but higher affinity than ketamine, it is orally active in a dosage range similar to ketamine, with some users requiring doses in excess of 100 mg for desired effects. Users have reported substantial differences in active dose, these discrepancies can be partially explained by the presence of unreacted PCC and other impurities in samples sold on the grey market. 4-MeO-PCP has Ki values of 404 nM for the NMDA receptor, 713 nM for the norepinephrine transporter, 844 nM for the serotonin transporter, 296 nM for the ?1 receptor and 143 nM for the ?2 receptor.
4-MeO-PCP hydrochloride is a white crystalline solid with a melting point of 181-182 °C
Shipping & Storage Information
Storage: -20°C
Shipping: Room Temperature in continental US; may vary elsewhere
Stability: ? 2 years
Technical Information
Formal Name: 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine, monohydrochloride
CAS Number: 2185-93-5
Purity: ?98%
Formulation: A crystalline solid
?max: 231, 272 nm
SMILES: COC(C=C1)=CC=C1C2(N3CCCCC3)CCCCC2.Cl
InChi CodeInChI=1S/C18H27NO.ClH/c1-20-17-10-8-16(9-11-17)18(12-4-2-5-13-18)19-14-6-3-7-15-19;/h8-11H,2-7,12-15H2,1H3;1H
InChi Key: FYAFJNVLHWQLHK-UHFFFAOYSA-N
Side effects
4-MeO-PCP has caused a fatality in combination with 4-HO-MET, venlafaxine, olanzapine, lorazepam and hydroxyzine.
Chemical and physical
Formula: C18H27NO
Molar mass: 273.420 g·mol?1
See also
Arylcyclohexylamine
3-HO-PCP
3-MeO-PCE
3-MeO-PCMo
3-MeO-PCP
Methoxetamine
Methoxyketamine
https://alpharesearchlab.net/product/buy-4-meo-pcp-crystal/
https://alpharesearchlab.net/product/buy-4-meo-pcp-crystal/
Buy ADB-FUBINACA Powder, ADB-FUBINACA Powder, ADB-FUBINACA Powder For Sale
Buy ADB-FUBINACA Powder is a designer drug identified in synthetic cannabis blends in Japan in 2013. In 2018, it was the third-most common synthetic cannabinoid identified in drugs seized by the Drug Enforcement Agency.
The (S)-enantiomer of ADB-FUBINACA is described in a 2009 Pfizer patent and has been reported to be a potent agonist of the CB1 receptor and the CB2 receptor with EC50 values of 1.2 nM and 3.5 nM, respectively. ADB-FUBINACA features a carboxamide group at the 3-indazole position, like SDB-001 and STS-135. ADB-FUBINACA appears to be the product of rational drug design, since it differs from AB-FUBINACA only by the replacement of the isopropyl group with a tert-butyl group.
An analogue of ADB-FUBINACA, ADSB-FUB-187, containing a more functionalized carboxamide substituent was recently reported.
Technical Information
Formal Name: N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide
CAS Number: 1445583-51-6
Molecular Formula: C21H23FN4O2
Formula Weight: 382.4
Purity: ?98%
Formulation: A neat solid
SMILES: O=C(NC(C(N)=O)C(C)(C)C)C1=NN(CC2=CC=C(F)C=C2)C3=C1C=CC=C3
InChi CodeInChI=1S/C21H23FN4O2/c1-21(2,3)18(19(23)27)24-20(28)17-15-6-4-5-7-16(15)26(25-17)12-13-8-10-14(22)11-9-13/h4-11,18H,12H2,1-3H3,(H2,23,27)(H,24,28)
InChi Key: ZSSGCSINPVBLQD-UHFFFAOYSA-N
DEA Schedule: I
Shipping & Storage Information
Storage: -20°C
Shipping: Room Temperature in continental US; may vary elsewhere
Stability: ? 3 years
Legality
In the United States, ADB-FUBINACA is a Schedule I controlled substance.
Metabolism
Twenty-three ADB-FUBINACA major metabolites were identified in several incubations with cryopreserved human hepatocytes. Major metabolic pathways were alkyl and indazole hydroxylation, terminal amide hydrolysis, subsequent glucuronide conjugations, and dehydrogenation
Side effects
One death through coronary arterial thrombosis has been linked to ADB-FUBINACA intoxication.
At least an additional 8 deaths in Hungary in 2015 are linked to the usage of this material, all deaths were youngsters below 21.
https://alpharesearchlab.net/product/buy-adb-fubinaca-powder/
https://alpharesearchlab.net/product/buy-adb-fubinaca-powder/
WARNING This product is not for human or veterinary use.
Buy 5-MeO-MIPT Powder
Buy 5-MeO-MIPT Powder (known by the street name Moxy or Moxie) is a psychedelic and hallucinogenic drug, used by some as an entheogen. It has structural and pharmacodynamic properties similar to the drugs 5-MeO-DiPT, DiPT, and MiPT. It is commonly used as a “substitute” for 5-MeO-DiPT because of the very similar structure and effects. This certified solution standard is suitable for Moxy testing methods by GC/MS or LC/MS testing applications in clinical toxicology, urine drug testing, or forensic analysis. The use of 5-MeO-MiPT has recently been reported in Europe.
Chemistry
5-MeO-MiPT is in a class of compounds commonly known as tryptamines, and is the N-methyl-N-isopropyl homologue of the psychedelic, 5-MeO-DMT. The full name of the chemical is 5-methoxy-N-methyl-N-isopropyltryptamine.
5-MeO-MiPT causes the ehrlich reagent to turn purple then fade to faint blue. It causes the marquis reagent to go yellow through to black.
Dosage
Orally, 5-MeO-MiPT is active at 4-6 mg. The drug can also be smoked, but unlike most other tryptamines, this route requires a much higher dosage. 10–20 mg is usually smoked. It typically produces a very strong odor.
Some users report activity as low as 1 mg while others report no activity up to 20 mg, this compound seems to be highly sensitive to the individual and any potential researchers should keep this in mind. Titrating the dose would be especially important with this compound.
Some users report little to no visual activity until doses of 10 mg or higher are taken. This chemical proves very useful for opening up and expressing oneself much like MDMA (3,4-methylenedioxymethamphetamine) and may be a useful chemical in psychedelic therapy.
Pharmacology
The mechanism that produces the hallucinogenic and entheogenic effects of 5-MeO-MiPT is thought to result primarily from 5-HT2A receptor agonism, although additional mechanisms of action such as inhibition of MAO may be involved also. 5-MeO-MiPT binds most strongly to 5-HT1A receptors; it also shows fairly strong binding affinity to the SERT and NET, thereby acting as a moderately potent serotonin-norepinephrine reuptake inhibitor. These mechanisms may help explain why there are many anecdotal reports of anti-depressant and anxiolytic effects from modest doses of this compound. For example, SNRIs such as venlafaxine are commonly prescribed to treat depression, and the 5-HT1A agonist buspirone is prescribed primarily for treatment of anxiety.
Chemical and physical data
Formula: C15H22N2O
Molar mass: 246.35 g/mol g·mol?1
See also
MIPT
5-MeO-DMT
5-MeO-DiPT
https://alpharesearchlab.net/product/buy-5-meo-mipt-powder/
https://alpharesearchlab.net/product/buy-5-meo-mipt-powder/
Buy BK-EBDP Powder
CAS: 727641-67-0
Formula: C14H19NO3
Purity: 99,7% min
Molecular weight: 249.310
Appearance: Powder
Synonyms: BK-EBDP, N-Ethylpentylone, BK-Ethyl-K
https://alpharesearchlab.net/product/buy-bk-ebdp-powder/
https://alpharesearchlab.net/product/buy-bk-ebdp-powder/
Opens in a new window
Tweet This Product
Opens in a new window
Buy 4-MeO-PCP CRYSTAL
Buy 4-MeO-PCP CRYSTAL 4-Methoxyphencyclidine (methoxydine, 4-MeO-PCP) is a dissociative anesthetic drug that has been sold online as a research chemical. The synthesis of 4-MeO-PCP was first reported in 1965 by the Parke-Davis medicinal chemist Victor Maddox. A 1999 review published by a chemist using the pseudonym John Q. Beagle suggested the potency of 4-MeO-PCP in man was reduced relative to PCP, two years later Beagle published a detailed description of the synthesis and qualitative effects of 4-MeO-PCP, which he said possessed 70% the potency of PCP. 4-MeO-PCP was the first arylcyclohexylamine research chemical to be sold online, it was introduced in late 2008 by a company trading under the name CBAY and was followed by several related compounds such as 3-MeO-PCP and methoxetamine.
4-MeO-PCP has lower affinity for the NMDA receptor than PCP, but higher affinity than ketamine, it is orally active in a dosage range similar to ketamine, with some users requiring doses in excess of 100 mg for desired effects. Users have reported substantial differences in active dose, these discrepancies can be partially explained by the presence of unreacted PCC and other impurities in samples sold on the grey market. 4-MeO-PCP has Ki values of 404 nM for the NMDA receptor, 713 nM for the norepinephrine transporter, 844 nM for the serotonin transporter, 296 nM for the ?1 receptor and 143 nM for the ?2 receptor.
4-MeO-PCP hydrochloride is a white crystalline solid with a melting point of 181-182 °C
Shipping & Storage Information
Storage: -20°C
Shipping: Room Temperature in continental US; may vary elsewhere
Stability: ? 2 years
Technical Information
Formal Name: 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine, monohydrochloride
CAS Number: 2185-93-5
Purity: ?98%
Formulation: A crystalline solid
?max: 231, 272 nm
SMILES: COC(C=C1)=CC=C1C2(N3CCCCC3)CCCCC2.Cl
InChi CodeInChI=1S/C18H27NO.ClH/c1-20-17-10-8-16(9-11-17)18(12-4-2-5-13-18)19-14-6-3-7-15-19;/h8-11H,2-7,12-15H2,1H3;1H
InChi Key: FYAFJNVLHWQLHK-UHFFFAOYSA-N
Side effects
4-MeO-PCP has caused a fatality in combination with 4-HO-MET, venlafaxine, olanzapine, lorazepam and hydroxyzine.
Chemical and physical
Formula: C18H27NO
Molar mass: 273.420 g·mol?1
See also
Arylcyclohexylamine
3-HO-PCP
3-MeO-PCE
3-MeO-PCMo
3-MeO-PCP
Methoxetamine
Methoxyketamine
https://alpharesearchlab.net/product/buy-4-meo-pcp-crystal/
https://alpharesearchlab.net/product/buy-4-meo-pcp-crystal/
Buy 6-MAPB Powder (1-(benzofuran-6-yl)-N-methylpropan-2-amine) is a psychedelic and entactogenic drug which is structurally related to 6-APB and MDMA. It is not known to have been widely sold as a designer drug but has been detected in analytical samples taken from individuals hospitalised after using drug combinations that included other benzofuran derivatives. 6-MAPB was banned in the UK in June 2013, along with 9 other related compounds which were thought to produce similar effects.
Buy 1-(benzofuran-6-yl)-N-methylpropan-2-amine) powder
Note: The rest of the comments are mostly for tracking the history of identifying the contents of this sample.
Initially, the lab’s GC/MS technique could not differentiate between 6-MAPB and 5-MAPB. The substance was tentatively identified as being either 6-MAPB or 5-MAPB.6-apb powder for sale
Erowid ordered several lab standards for similar substances that the lab used to calibrate their GC/MS equipment to better be able to identify this class of substances. After examining these new chemical standards, the lab changed its identification of this sample 6-APDB.
This identification is still tentative because we have not yet been able to acquire a lab standard for 6-APDB. However, the lab is confident that the sample submitted is NOT an -MAPB or -APB.6-apb buy
Effects
The reported effect is the feeling of energy and euphoria, which are as high as those after the ecstasy consumption. The drug is able to increase music appreciation along with trippy and empathogenic qualities. Along with positive results, people who buy 6-MAPB online also report some adverse ones, namely:
hallucinations;
insomnia;
appetite loss and weight loss;
paranoia (severe stage);
tachycardia;
jaw tension.
Researchers warn most users about possible brain damage as well as neurotoxicity, serotonin syndrome. Other adverse body reactions are closely related to those experienced after the intake of MDA. They are more severe than MDMA results. Besides, 6-MAPB for sale can trigger addiction that is as serious as in case with most amphetamines.
Doses can be light (20-40 mg), regular (40-80 mg) and strong ones (80-100 mg). When the agent is insufflated, the doses must be lower to achieve the same results: light – 10-20 mg, regular – 20-40 mg and strong ones – 40-100 mg. When the drug is consumed orally it starts acting within several minutes and promises effects that last for 5 or 10 hours. The after effects remain for nearly 4 more hours. If the compound is insufflated, it works just the same as in case when taken orally.
Chemical and physical data
Formula: C12H15NO
Molar mass: 189.25 g·mol?1
https://alpharesearchlab.net/product/buy-6-mapb-powder/
https://alpharesearchlab.net/product/buy-6-mapb-powder/
Opens in a new wi
Opens in a new window
Buy 4-MeO-PCP CRYSTAL
Buy 4-MeO-PCP CRYSTAL 4-Methoxyphencyclidine (methoxydine, 4-MeO-PCP) is a dissociative anesthetic drug that has been sold online as a research chemical. The synthesis of 4-MeO-PCP was first reported in 1965 by the Parke-Davis medicinal chemist Victor Maddox. A 1999 review published by a chemist using the pseudonym John Q. Beagle suggested the potency of 4-MeO-PCP in man was reduced relative to PCP, two years later Beagle published a detailed description of the synthesis and qualitative effects of 4-MeO-PCP, which he said possessed 70% the potency of PCP. 4-MeO-PCP was the first arylcyclohexylamine research chemical to be sold online, it was introduced in late 2008 by a company trading under the name CBAY and was followed by several related compounds such as 3-MeO-PCP and methoxetamine.
4-MeO-PCP has lower affinity for the NMDA receptor than PCP, but higher affinity than ketamine, it is orally active in a dosage range similar to ketamine, with some users requiring doses in excess of 100 mg for desired effects. Users have reported substantial differences in active dose, these discrepancies can be partially explained by the presence of unreacted PCC and other impurities in samples sold on the grey market. 4-MeO-PCP has Ki values of 404 nM for the NMDA receptor, 713 nM for the norepinephrine transporter, 844 nM for the serotonin transporter, 296 nM for the ?1 receptor and 143 nM for the ?2 receptor.
4-MeO-PCP hydrochloride is a white crystalline solid with a melting point of 181-182 °C
Shipping & Storage Information
Storage: -20°C
Shipping: Room Temperature in continental US; may vary elsewhere
Stability: ? 2 years
Technical Information
Formal Name: 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine, monohydrochloride
CAS Number: 2185-93-5
Purity: ?98%
Formulation: A crystalline solid
?max: 231, 272 nm
SMILES: COC(C=C1)=CC=C1C2(N3CCCCC3)CCCCC2.Cl
InChi CodeInChI=1S/C18H27NO.ClH/c1-20-17-10-8-16(9-11-17)18(12-4-2-5-13-18)19-14-6-3-7-15-19;/h8-11H,2-7,12-15H2,1H3;1H
InChi Key: FYAFJNVLHWQLHK-UHFFFAOYSA-N
Side effects
4-MeO-PCP has caused a fatality in combination with 4-HO-MET, venlafaxine, olanzapine, lorazepam and hydroxyzine.
Chemical and physical
Formula: C18H27NO
Molar mass: 273.420 g·mol?1
See also
Arylcyclohexylamine
3-HO-PCP
3-MeO-PCE
3-MeO-PCMo
3-MeO-PCP
Methoxetamine
Methoxyketamine
https://alpharesearchlab.net/product/buy-4-meo-pcp-crystal/
https://alpharesearchlab.net/product/buy-4-meo-pcp-crystal/
Buy ADB-FUBINACA Powder, ADB-FUBINACA Powder, ADB-FUBINACA Powder For Sale
Buy ADB-FUBINACA Powder is a designer drug identified in synthetic cannabis blends in Japan in 2013. In 2018, it was the third-most common synthetic cannabinoid identified in drugs seized by the Drug Enforcement Agency.
The (S)-enantiomer of ADB-FUBINACA is described in a 2009 Pfizer patent and has been reported to be a potent agonist of the CB1 receptor and the CB2 receptor with EC50 values of 1.2 nM and 3.5 nM, respectively. ADB-FUBINACA features a carboxamide group at the 3-indazole position, like SDB-001 and STS-135. ADB-FUBINACA appears to be the product of rational drug design, since it differs from AB-FUBINACA only by the replacement of the isopropyl group with a tert-butyl group.
An analogue of ADB-FUBINACA, ADSB-FUB-187, containing a more functionalized carboxamide substituent was recently reported.
Technical Information
Formal Name: N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide
CAS Number: 1445583-51-6
Molecular Formula: C21H23FN4O2
Formula Weight: 382.4
Purity: ?98%
Formulation: A neat solid
SMILES: O=C(NC(C(N)=O)C(C)(C)C)C1=NN(CC2=CC=C(F)C=C2)C3=C1C=CC=C3
InChi CodeInChI=1S/C21H23FN4O2/c1-21(2,3)18(19(23)27)24-20(28)17-15-6-4-5-7-16(15)26(25-17)12-13-8-10-14(22)11-9-13/h4-11,18H,12H2,1-3H3,(H2,23,27)(H,24,28)
InChi Key: ZSSGCSINPVBLQD-UHFFFAOYSA-N
DEA Schedule: I
Shipping & Storage Information
Storage: -20°C
Shipping: Room Temperature in continental US; may vary elsewhere
Stability: ? 3 years
Legality
In the United States, ADB-FUBINACA is a Schedule I controlled substance.
Metabolism
Twenty-three ADB-FUBINACA major metabolites were identified in several incubations with cryopreserved human hepatocytes. Major metabolic pathways were alkyl and indazole hydroxylation, terminal amide hydrolysis, subsequent glucuronide conjugations, and dehydrogenation
Side effects
One death through coronary arterial thrombosis has been linked to ADB-FUBINACA intoxication.
At least an additional 8 deaths in Hungary in 2015 are linked to the usage of this material, all deaths were youngsters below 21.
https://alpharesearchlab.net/product/buy-adb-fubinaca-powder/
https://alpharesearchlab.net/product/buy-adb-fubinaca-powder/
WARNING This product is not for human or veterinary use.
Buy 5-MeO-MIPT Powder
Buy 5-MeO-MIPT Powder (known by the street name Moxy or Moxie) is a psychedelic and hallucinogenic drug, used by some as an entheogen. It has structural and pharmacodynamic properties similar to the drugs 5-MeO-DiPT, DiPT, and MiPT. It is commonly used as a “substitute” for 5-MeO-DiPT because of the very similar structure and effects. This certified solution standard is suitable for Moxy testing methods by GC/MS or LC/MS testing applications in clinical toxicology, urine drug testing, or forensic analysis. The use of 5-MeO-MiPT has recently been reported in Europe.
Chemistry
5-MeO-MiPT is in a class of compounds commonly known as tryptamines, and is the N-methyl-N-isopropyl homologue of the psychedelic, 5-MeO-DMT. The full name of the chemical is 5-methoxy-N-methyl-N-isopropyltryptamine.
5-MeO-MiPT causes the ehrlich reagent to turn purple then fade to faint blue. It causes the marquis reagent to go yellow through to black.
Dosage
Orally, 5-MeO-MiPT is active at 4-6 mg. The drug can also be smoked, but unlike most other tryptamines, this route requires a much higher dosage. 10–20 mg is usually smoked. It typically produces a very strong odor.
Some users report activity as low as 1 mg while others report no activity up to 20 mg, this compound seems to be highly sensitive to the individual and any potential researchers should keep this in mind. Titrating the dose would be especially important with this compound.
Some users report little to no visual activity until doses of 10 mg or higher are taken. This chemical proves very useful for opening up and expressing oneself much like MDMA (3,4-methylenedioxymethamphetamine) and may be a useful chemical in psychedelic therapy.
Pharmacology
The mechanism that produces the hallucinogenic and entheogenic effects of 5-MeO-MiPT is thought to result primarily from 5-HT2A receptor agonism, although additional mechanisms of action such as inhibition of MAO may be involved also. 5-MeO-MiPT binds most strongly to 5-HT1A receptors; it also shows fairly strong binding affinity to the SERT and NET, thereby acting as a moderately potent serotonin-norepinephrine reuptake inhibitor. These mechanisms may help explain why there are many anecdotal reports of anti-depressant and anxiolytic effects from modest doses of this compound. For example, SNRIs such as venlafaxine are commonly prescribed to treat depression, and the 5-HT1A agonist buspirone is prescribed primarily for treatment of anxiety.
Chemical and physical data
Formula: C15H22N2O
Molar mass: 246.35 g/mol g·mol?1
See also
MIPT
5-MeO-DMT
5-MeO-DiPT
https://alpharesearchlab.net/product/buy-5-meo-mipt-powder/
https://alpharesearchlab.net/product/buy-5-meo-mipt-powder/
Buy BK-EBDP Powder
CAS: 727641-67-0
Formula: C14H19NO3
Purity: 99,7% min
Molecular weight: 249.310
Appearance: Powder
Synonyms: BK-EBDP, N-Ethylpentylone, BK-Ethyl-K
https://alpharesearchlab.net/product/buy-bk-ebdp-powder/
https://alpharesearchlab.net/product/buy-bk-ebdp-powder/
Opens in a new window
Tweet This Product
Opens in a new window
Buy 4-MeO-PCP CRYSTAL
Buy 4-MeO-PCP CRYSTAL 4-Methoxyphencyclidine (methoxydine, 4-MeO-PCP) is a dissociative anesthetic drug that has been sold online as a research chemical. The synthesis of 4-MeO-PCP was first reported in 1965 by the Parke-Davis medicinal chemist Victor Maddox. A 1999 review published by a chemist using the pseudonym John Q. Beagle suggested the potency of 4-MeO-PCP in man was reduced relative to PCP, two years later Beagle published a detailed description of the synthesis and qualitative effects of 4-MeO-PCP, which he said possessed 70% the potency of PCP. 4-MeO-PCP was the first arylcyclohexylamine research chemical to be sold online, it was introduced in late 2008 by a company trading under the name CBAY and was followed by several related compounds such as 3-MeO-PCP and methoxetamine.
4-MeO-PCP has lower affinity for the NMDA receptor than PCP, but higher affinity than ketamine, it is orally active in a dosage range similar to ketamine, with some users requiring doses in excess of 100 mg for desired effects. Users have reported substantial differences in active dose, these discrepancies can be partially explained by the presence of unreacted PCC and other impurities in samples sold on the grey market. 4-MeO-PCP has Ki values of 404 nM for the NMDA receptor, 713 nM for the norepinephrine transporter, 844 nM for the serotonin transporter, 296 nM for the ?1 receptor and 143 nM for the ?2 receptor.
4-MeO-PCP hydrochloride is a white crystalline solid with a melting point of 181-182 °C
Shipping & Storage Information
Storage: -20°C
Shipping: Room Temperature in continental US; may vary elsewhere
Stability: ? 2 years
Technical Information
Formal Name: 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine, monohydrochloride
CAS Number: 2185-93-5
Purity: ?98%
Formulation: A crystalline solid
?max: 231, 272 nm
SMILES: COC(C=C1)=CC=C1C2(N3CCCCC3)CCCCC2.Cl
InChi CodeInChI=1S/C18H27NO.ClH/c1-20-17-10-8-16(9-11-17)18(12-4-2-5-13-18)19-14-6-3-7-15-19;/h8-11H,2-7,12-15H2,1H3;1H
InChi Key: FYAFJNVLHWQLHK-UHFFFAOYSA-N
Side effects
4-MeO-PCP has caused a fatality in combination with 4-HO-MET, venlafaxine, olanzapine, lorazepam and hydroxyzine.
Chemical and physical
Formula: C18H27NO
Molar mass: 273.420 g·mol?1
See also
Arylcyclohexylamine
3-HO-PCP
3-MeO-PCE
3-MeO-PCMo
3-MeO-PCP
Methoxetamine
Methoxyketamine
https://alpharesearchlab.net/product/buy-4-meo-pcp-crystal/
https://alpharesearchlab.net/product/buy-4-meo-pcp-crystal/
Reply all
Reply to author
Forward
0 new messages